Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious ...Middle East

Yahoo - News
Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious
Scientists on Monday said initial trial results for Pfizer Inc and BioNTech's coronavirus vaccine far outpaced their expectations for protection against a completely new disease, but that many questions remain unanswered. The drugmakers said their vaccine was more than 90 percent effective at preventing COVID-19, based on data from the first 94 people in the trial to become infected with the coronavirus. The 44,000-volunteer study was initially designed for a first interim analysis of whether the vaccine was working after 32 participants developed COVID-19.

Hence then, the article about pfizer biontech initial vaccine results impress but scientists remain cautious was published today ( ) and is available on Yahoo ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Pfizer, BioNTech initial vaccine results impress, but scientists remain cautious )

Apple Storegoogle play

Last updated :

Also on site :